Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    "Penile Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Penile Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
Condition: Locally-advanced or Metastatic Penile Neoplasms
Intervention: Drug: Vinflunine
2 Unknown  Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis
Conditions: Penile Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Dacomitinib
3 Completed Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
Condition: Penile Cancer
Interventions: Drug: cisplatin;   Drug: irinotecan hydrochloride;   Procedure: neoadjuvant therapy
4 Terminated S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Condition: Penile Cancer
Intervention: Drug: docetaxel
5 Recruiting Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]
Condition: Squamous Cell Carcinoma of the Penis
Intervention: Procedure: MRI-PET
6 Active, not recruiting Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Conditions: Penile Cancer;   Erectile Dysfunction;   Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires;   Drug: Sildenafil and questionnaire;   Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires
7 Active, not recruiting Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
Conditions: Penile Cancer;   Squamous Carcinoma
Intervention: Drug: Chemotherapie TIP
8 Withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP
9 Completed
Has Results
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
Condition: Penile Cancer
Interventions: Drug: Ifosfamide;   Drug: Paclitaxel (Taxol);   Drug: Cisplatin
10 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
11 Completed T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions: Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: Aldesleukin
12 Completed Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fludarabine;   Drug: Cycolphosphamide;   Biological: Young TIL;   Drug: Aldesleukin
13 Active, not recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
14 Completed Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Conditions: Anal Cancer;   Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Penile Cancer;   Vulvar Cancer
Interventions: Biological: human papillomavirus 16 E7 peptide;   Biological: synthetic human papillomavirus 16 E6 peptide
15 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis, High Risk Individuals, and Individuals With No History of Cancer (Control)
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breastcancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer
Intervention:
16 Completed
Has Results
Cancer in Patients With Gabapentin (GPRD)
Conditions: Pain, Neuropathic;   Epilepsy;   Renal Pelvis Cancer;   Pancreatic Cancer;   Breast Cancer;   Nervous System Cancer;   Chronic Pancreatitis;   Stomach Cancer;   Renal Cell Carcinoma;   Diabetes;   Bladder Cancer;   Bone and Joint Cancer;   Penis Cancer;   Anal Cancer;   Cancer;   Renal Cancer
Intervention: Drug: Gabapentin prescriptions
17 Completed Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Conditions: Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Non-melanomatous Skin Cancer;   Penile Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: isotretinoin

Study has passed its completion date and status has not been verified in more than two years.